南京医药

- 600713

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
南京医药(600713) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入1,395,254.505,358,966.474,054,678.262,734,312.451,408,179.05
营业收入1,395,254.505,358,966.474,054,678.262,734,312.451,408,179.05
二、营业总成本1,366,272.295,264,543.923,980,713.792,684,226.171,382,210.17
营业成本1,311,184.765,027,636.173,808,338.092,570,622.851,326,800.14
营业税金及附加2,544.6410,759.287,371.194,454.912,064.68
销售费用28,136.47117,310.0785,887.3056,713.8528,792.15
管理费用10,195.9551,744.3436,168.5823,865.2011,103.75
财务费用13,187.1653,475.1540,097.8726,779.2712,612.68
研发费用1,023.323,618.912,850.761,790.09836.76
资产减值损失----------
公允价值变动收益----------
投资收益10.54858.10870.77396.06-74.84
其中:对联营企业和合营企业的投资收益-6.46606.17625.38389.56-74.84
汇兑收益----------
三、营业利润26,354.19100,744.2775,469.3353,537.1725,213.45
加:营业外收入362.04256.64237.41159.6530.16
减:营业外支出494.723,194.102,488.711,544.70739.31
其中:非流动资产处置损失----------
四、利润总额26,221.5297,806.8173,218.0352,152.1224,504.30
减:所得税费用6,526.8126,525.9219,921.5814,573.006,143.79
五、净利润19,694.7171,280.8953,296.4537,579.1118,360.51
归属于母公司所有者的净利润15,908.2757,782.5644,029.5430,864.1914,915.79
少数股东损益3,786.4413,498.339,266.916,714.933,444.73
六、每股收益
基本每股收益(元/股)0.12300.44500.34000.23700.1140
稀释每股收益(元/股)0.12300.44500.34000.23700.1140
七、其他综合收益-622.96753.61502.90886.911,748.85
八、综合收益总额19,071.7572,034.5153,799.3538,466.0220,109.36
归属于母公司所有者的综合收益总额15,313.4258,557.4244,566.3331,755.0316,647.09
归属于少数股东的综合收益总额3,758.3313,477.099,233.026,710.993,462.27
下载全部历史数据到excel中 返回页顶